Medical Oncology

Prof. Dr. Hüseyin Mertsoylu

Doctor and researcher Medical Park Adana Adana
Nasopharyngeal NeoplasmsBrain NeoplasmsCarcinoma, Non-Small-Cell LungLung NeoplasmsNasopharyngeal CarcinomaGlioblastomaNeoplasmsTrismusStomach NeoplasmsAdenocarcinomaCarcinoma, Squamous CellOsteoradionecrosisHead and Neck NeoplasmsAnemiaKidney Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Nasopharyngeal Neoplasms 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Brain Neoplasms 7 publications
  • Carcinoma, Non-Small-Cell Lung 7 publications
  • Lung Neoplasms 7 publications
  • Nasopharyngeal Carcinoma 6 publications
  • Glioblastoma 6 publications
  • Neoplasms 4 publications
  • Trismus 3 publications
  • Stomach Neoplasms 3 publications
  • Adenocarcinoma 3 publications
  • Carcinoma, Squamous Cell 3 publications
  • Osteoradionecrosis 2 publications
  • Head and Neck Neoplasms 2 publications
  • Anemia 2 publications
  • Kidney Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • İmmünoterapi
  • Jinekolojik kanserler
  • Lenfoma
  • Meme kanseri
  • Prostat kanseri
  • Akciğer kanseri
  • Kolorektal kanserler
  • Hedefleyici tedavi kişiye özel tedavi

CV

Education and experience

From source

Education

  • EducationHacettepe Üniversitesi Tıp Fakültesi (İng) 1992-1999medicalpark.com.tr
  • EducationGazi Üniversitesi Tıp Fakültesi, İç Hastalıkları AD 2000-2005medicalpark.com.tr
  • EducationBaşkent Üniversitesi Tıp fakültesi, İç Hastalıkları AD., Tıbbi Onkoloji BD 2006-2009medicalpark.com.tr
  • EducationTıbbi Onkoloji Uzmanlığı Mecburi Hizmet Şanlıurfa Eğitim ve Araştırma Hastanesi (2 yıl) 2009-2011medicalpark.com.tr
  • EducationBaşkent Üniversitesi Tıp fakültesi, İç Hastalıkları AD., Tıbbi Onkoloji BD 2011-2023medicalpark.com.tr
  • EducationDoçentlik Tarihi: 19.10.2016medicalpark.com.tr
  • EducationProfosörlük tarihi: 03.12.2021medicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • InstitutionMedical Park Adanamedicalpark.com.trFrom source
  • Area of workNasopharyngeal NeoplasmsExtracted from 7 publications · Model version —From source
  • Publications113 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-1932-9784ORCIDFrom source
  • Last synchronised4 November 2026 20:28https://www.medicalpark.com.tr/hekimler/huseyin-mertsoylumedicalpark.com.tr

Scientific work

Publications on Nasopharyngeal Neoplasms

113 publications

  1. Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study

    Indian Journal of Surgical Oncology, 2024

    DOI 10.1007/s13193-024-02045-2 PMID 39328732 1 citation (Europe PMC) Open-access full textSource: ORCID

  2. Letter to Editor: “The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors”

    Ear, Nose and Throat Journal, 2024

    DOI 10.1177/01455613241249268 PMID 38656170 Open-access full textSource: ORCID

  3. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients

    Tomography, 2024

    DOI 10.3390/tomography10010007 PMID 38250953 2 citations (Europe PMC) Open-access full textSource: ORCID

  4. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas

    International Journal of Biological Markers, 2024

    DOI 10.1177/03936155231223198 PMID 38192114 9 citations (Europe PMC) Open-access full textSource: ORCID

  5. Novel Index Combining Pan‐Immune‐Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer

    International Journal of Surgical Oncology, 2024

    DOI 10.1155/2024/2124006 PMID 39376995 2 citations (Europe PMC) Open-access full textSource: ORCID

  6. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients

    Journal of Stomatology, Oral and Maxillofacial Surgery, 2024

    DOI 10.1016/j.jormas.2024.101838 PMID 38518893 2 citations (Europe PMC) Source: ORCID

  7. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas

    Journal of Stomatology, Oral and Maxillofacial Surgery, 2024

    DOI 10.1016/j.jormas.2024.101786 PMID 38286220 1 citation (Europe PMC) Source: ORCID

  8. The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol

    International Journal of Immunopathology and Pharmacology, 2024

    DOI 10.1177/03946320241284089 PMID 39305006 5 citations (Europe PMC) Open-access full textSource: ORCID

  9. The Predictive Power of Biomarkers in Osteoradionecrosis

    Interdisciplinary cancer research, 2024

    DOI 10.1007/16833_2024_266 2 citations (OpenAlex) Source: OpenAlex

  10. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer

    Discover Oncology, 2023

    DOI 10.1007/s12672-023-00851-8 PMID 38091179 5 citations (Europe PMC) Open-access full textSource: ORCID

View all 113 publications